lysophosphatidic acid has been researched along with Disease Models, Animal in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (5.68) | 29.6817 |
2010's | 60 (68.18) | 24.3611 |
2020's | 23 (26.14) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Chan, AWH; Coker, OO; Lau, HCH; Li, C; Lin, Y; Sung, JJY; Szeto, CH; Wei, H; Yang, J; Yu, J; Zhou, Y | 1 |
Chen, SU; Chou, CH; Shun, CT; Tsao, PN; Tu, YA; Wen, WF; Yang, JH; Yang, PK | 1 |
Jendzjowsky, NG; Roy, A; Wilson, RJA | 1 |
Giménez-Llort, L; González de San Román, E; Llorente-Ovejero, A; Manuel, I; Martínez-Gardeazabal, J; Moreno-Rodríguez, M; Rodríguez-Puertas, R | 1 |
McDougall, JJ; Reid, AR | 1 |
Ara, H; Bhattarai, S; Bhuiyan, MS; Kidambi, S; Milena, M; Miriyala, S; Panchatcharam, M; Sharma, S; Shum, A; Subedi, U; Sun, H | 1 |
Im, DS; Lee, YJ | 1 |
Gotoh, M; Ishizuka, T; Koizumi, A; Nagata, W; Nakagawa, K; Satoh, Y; Takahashi, S | 1 |
Bhattarai, S; Manikandan, S; Miriyala, S; Panchatcharam, M; Sharma, P; Sharma, S; Subedi, U; Sun, H | 1 |
Beattie, G; Brigode, W; Cohan, C; Miraflor, E; Victorino, GP; Yeung, L | 1 |
Chen, L; Deng, X; Liu, Y; Yang, X; Yu, C; Zhang, J | 1 |
Kittaka, H; Tominaga, M; Yamanoi, Y | 1 |
Blaho, VA; Chun, J; Frantz, AJ; Kennedy, G; Kihara, Y; Lummis, NC; Sánchez-Pavón, P | 1 |
Aoki, J; Ikeda, H; Ito, N; Kano, K; Kurano, M; Saigusa, D; Saito, R; Sekiguchi, M; Sumitani, M; Uranbileg, B; Uruno, A; Yamada, Y; Yatomi, Y | 1 |
Fu, WW; Li, L; Li, WJ; Song, YH; Wu, RT; Wu, WY; Xie, MY; Yin, SH | 1 |
Kim, SJ; Moon, HG; Park, GY | 1 |
Chi, OZ; Chiricolo, A; Kiss, GK; Liu, X; Mellender, SJ; Weiss, HR | 1 |
Engevik, AC; Goldenring, JR; Goldstein, AE; Hodges, CA; Kaji, I; Roland, JT; Watanabe, M | 1 |
Azuma, M; Bando, H; Kondo, M; Koyama, K; Nishioka, Y; Ogawa, H; Tezuka, T | 1 |
Chi, OZ; Chiricolo, A; Jacinto, E; Kiss, GK; Liu, X; Mellender, SJ; Patel, N; Weiss, HR | 1 |
Chen, BPC; Chen, SK; Chen, WM; Chiang, JC; Ho, YH; Hsia, K; Lee, H; Lin, KH; Lin, YC; Lu, JH; Shen, TL; Yao, CL | 1 |
Kobayashi, K; Masuko, S; Matsushita, S; Murata, T; Shimizu, N; Yamamoto, M | 1 |
Aoki, J; Ito, N; Kano, K; Kurano, M; Sumitani, M; Uchida, K; Uranbileg, B; Yatomi, Y | 1 |
Dong, L; Han, Y; He, P; Wang, M; Yun, CC | 1 |
Burman, A; Engevik, AC; Goldenring, JR; Goldstein, AE; Kaji, I; Rathan-Kumar, S; Roland, JT; Watanabe, M | 1 |
Beaulac, HJ; Gilels, F; Jeoung, S; White, PM; Zhang, J | 1 |
Clark, JD; Eisenried, A; Klukinov, M; Meidahl, ACN; Sabbadini, RA; Tzabazis, AZ; Yeomans, DC | 1 |
Brandan, E; Contreras, O; Riquelme-Guzmán, C | 1 |
Akahoshi, N; Araki, K; Araki, M; Gotoh, M; Ishii, S; Murakami-Murofushi, K; Neyama, H; Sumida, H; Tsukahara, R; Tsukahara, T; Ueda, H; Yamamoto, S; Yamamura, KI; Yanagida, K; Yoshikawa, K | 1 |
Aoki, J; Cheng, H; Distler, U; Endle, H; Geisslinger, G; Hauser, MJ; Horta, G; Kirischuk, S; Laube, G; Luhmann, HJ; Morris, AJ; Nitsch, R; Qiao, L; Radyushkin, K; Röper, J; Sigurdsson, T; Tegeder, I; Tenzer, S; Thalman, C; Vogt, J | 1 |
Matsushita, Y; Nagai, J; Neyama, H; Tsukahara, R; Tsukahara, T; Ueda, H | 1 |
McDougall, JJ; O'Brien, MS; Philpott, HTA | 1 |
Aoki, J; Chun, J; Inoue, A; Ishii, S; Kanai, M; Kano, K; Matsumoto, H; Shimizu, T; Yukiura, H | 1 |
Chen, QY; Deng, SJ; Dong, YL; Duan, XY; Fan, H; Liu, YJ; Nan, Z; Wu, H; Xu, M | 1 |
Castilla-Ortega, E; Chun, J; Estivill-Torrús, G; García-Fernández, M; Pedraza, C; Rodriguez de Fonseca, F; Rosell-Valle, C; Sánchez-López, J; Santín, LJ; Zambrana-Infantes, E | 1 |
Ma, L; Nagai, J; Ueda, H; Yano, R | 1 |
Ackerman, SJ; Aidinis, V; Berdyshev, E; Christman, JW; Chun, J; Chung, S; Corbridge, SJ; Deng, J; Du, J; Fu, P; Gorshkova, IA; Jaffe, HA; Jarjour, NN; Kaffe, E; Karpurapu, M; Kelly, EA; Lee, YG; Li, Y; Morris, AJ; Natarajan, V; Ninou, I; Nyenhuis, S; Park, GY; Prestwich, GD; Ranjan, R; Smyth, SS; Xiao, L | 1 |
Bao, S; Day, R; Tan, C; Turk, J; Zhao, QD | 1 |
Conquest, A; Crack, PJ; Daglas, M; Fleming, JK; Goldshmit, Y; Johnston, LA; Karve, I; Medcalf, RL; Morganti-Kossmann, MC; Morris, AJ; Pébay, A; Sabbadini, RA; Sashindranath, M; Wojciak, JM; Wright, D; Zhang, M | 1 |
Amin, MA; Campbell, P; Fox, DA; Haak, AJ; Khanna, D; Larsen, SD; Neubig, RR; Ruth, JH; Tsou, PS | 1 |
Caeiro, JR; Conde, C; Gómez-Reino, JJ; González, A; Guede, D; Martínez, P; Orosa, B | 1 |
Hashimoto, T; Oka, J; Saitoh, A; Tsukagoshi, M; Yamada, M | 1 |
Nagai, J; Uchida, H; Ueda, H | 1 |
Chun, J; De Loera, C; Inomata, Y; Mirendil, H; Okada, K; Thomas, EA | 1 |
Bourgoin, SG; Davis, L; Fernandes, MJ; Poubelle, PE; Sardella, A; Zhao, C | 1 |
Astudillo, AM; Balsinde, J; Chun, J; de Fonseca, FR; Estivill-Torrús, G; Hernández, J; Lago, N; López-Serrano, C; López-Vales, R; Santos-Nogueira, E | 1 |
Aronin, N; DiFiglia, M; Green, KM; Iuliano, M; Kegel-Gleason, KB; Mo, S; Sadri-Vakili, G; Sapp, E; Shaffer, SA; Tousley, A; Vodicka, P | 1 |
Aday, S; Cardoso, C; Carvalheiro, T; Carvalho, L; Duarte, A; Ferreira, L; Fidalgo-Carvalho, I; Gonçalves, L; Grãos, M; Kostic, I; Paiva, A; Vazão, H | 1 |
Hwang, YS; Lee, J; Lindholm, PF; Zhang, X | 1 |
Ackerman, SJ; Berdyshev, E; Christman, JW; Natarajan, V; Nyenhuis, S; Park, GY | 1 |
Bain, G; Black, KE; Castelino, FV; George, L; Goulet, L; Lafyatis, R; Pace, VA; Probst, CK; Tager, AM | 1 |
Davies, MR; Feeley, BT; Kim, HT; Lee, L; Liu, X | 1 |
Almog, G; Ben-Hamo, R; Brandis, A; Braun, T; Efroni, S; Ely, Y; Feldmesser, E; Gibbs-Bar, L; Hofi, R; Tempelhof, H; Yaniv, K | 1 |
Lin, W; Liu, BL; Pan, HL; Zhang, YQ | 1 |
Baïotto, A; Bascands, JL; Bertrand-Michel, J; Denis, C; Dupuy, A; Klein, J; Marsal, D; Mirzoyan, K; Saulnier-Blache, JS; Schanstra, JP; Sicard, P; Vinel, C | 1 |
Dhanasekaran, DN; Gomathinayagam, R; Ha, JH; Husain, S; Jayaraman, M; Liu, J; Mukherjee, P; Reddy, EP; Song, YS; Yan, M | 1 |
Bot, I; Kritikou, E; Kröner, MJ; Kuiper, J; Schaftenaar, FH; Swart, M; van der Heijden, T; van Puijvelde, GH; van Santbrink, PJ | 1 |
Inoue, M; Ishihara, A; Okamoto, Y; Tokumura, A; Tsutsumi, T | 1 |
Choi, JW; Jun, HS; Jung, JY; Li, HY; Oh, YS | 1 |
Brindley, DN; Curtis, JM; Tang, X; Wang, X; Zhao, YY | 1 |
Aguilera-Barrantes, I; Cao, Q; Chen, Y; Cheng, YC; Dong, L; Opansky, C; Ren, B; Sahoo, D; Silverstein, RL; Wu, S; Yuan, R; Yuan, Y | 1 |
Chen, M; Chun, J; de Jonge, HR; Donowitz, M; He, P; Hogema, BM; Lamprecht, G; Lin, S; Seidler, U; Singh, AK; Tse, M; Yeruva, S; Yun, CC; Zhang, H | 1 |
Chun, J; Evgeny, B; He, D; Natarajan, V; Pendyala, S; Sperling, AI; Tong, J; Zhao, Y | 1 |
Chun, J; Nagai, J; Uchida, H; Ueda, H; Ueda, M; Xie, W | 1 |
Beuers, U; Geenes, VL; Kondrackiene, J; Kremer, AE; Kuiper, EM; Kulik, W; Martens, JJ; Moolenaar, WH; Oude Elferink, RP; Prieto, J; Ruëff, F; Rust, C; van Buuren, HR; van Erpecum, KJ; Williamson, C | 1 |
Li, TT; Pan, HL; Wei, JY; Zhang, YQ; Zhao, J; Zhao, ZQ | 1 |
Amneus, MW; Anantharamaiah, GM; Farias-Eisner, G; Farias-Eisner, R; Fogelman, AM; Gao, F; Grijalva, V; Hough, G; Imaizumi, S; Kozak, KR; Navab, M; Ng, C; Reddy, ST; Su, F; Van Lenten, BJ; Wagner, A | 1 |
Hall, RA; Lee, SJ; Ritter, SL; Shim, H; Yun, CC; Zhang, H | 1 |
Colom, A; Dusaulcy, R; Grès, S; Guigné, C; Moolenaar, WH; Rancoule, C; Saulnier-Blache, JS; Valet, P; van Meeteren, LA; Wanecq, E | 1 |
Anantharamaiah, GM; Fogelman, AM; Hama, S; Hough, G; Imaizumi, S; Navab, M; Reddy, ST | 1 |
Beuers, U; Kremer, AE; Oude Elferink, RP | 1 |
Beuers, UH; Kremer, AE; Martens, JJ; Oude Elferink, RP | 1 |
Choi, JW; Chun, J; Kingsbury, MA; Lin, ME; Mutoh, T; Noguchi, K; Rivera, RR; Yung, YC | 1 |
Chun, J; Funke, M; Tager, AM; Xu, Y; Zhao, Z | 1 |
Chevalier, E; Dembowsky, K; Hamesch, K; Li, X; Schober, A; Subramanian, P; Weber, C | 1 |
Kato, A; Ogawa, K; Shinohara, S; Takasu, K; Yoneda, Y | 1 |
Balys, M; Chapman, TJ; Emo, J; Georas, SN; Meednu, N; Randall, T; Rangasamy, T; Rezaee, F | 1 |
Alessi, D; Gan, X; Kozasa, T; Offermanns, S; Simon, MI; Sommer, E; Srinivasula, S; Wang, C; Wang, J; Wu, D | 1 |
Crombie, D; Currie, PD; Ellett, F; Frisca, F; Goldshmit, Y; Lieschke, GJ; Matteo, R; Moreno, K; Pébay, A; Sabbadini, RA; Sztal, T | 1 |
Abu El-Asrar, AM; Kangave, D; Mohammad, G; Nawaz, MI; Opdenakker, G; Siddiquei, MM | 1 |
Hayashi, Y; Inoue, K; Nakanishi, H; Peters, C; Sun, L; Tsuda, M; Wu, Z | 1 |
Dong, A; Escalante-Alcalde, D; Miriyala, S; Morris, AJ; Mueller, P; Panchatcharam, M; Salous, A; Smyth, SS; Sunkara, M; Wheeler, J | 1 |
Chun, J; Duffield, JS; Luster, AD; Sakai, N; Tager, AM; Wada, T | 1 |
Kitayama, J; Nagawa, H; Ohta, H; Sakai, T; Sako, A; Shida, D; Suzuki, R | 1 |
Dhallu, MS; Malhotra, S; Mammis, A; Ocava, LC; Rosenbaum, DM; Rosenbaum, PS; Savitz, SI | 1 |
Chen, S; Clegg, T; Estwick, SA; Hingtgen, CM; Li, X; Li, Y; Ming, W; Nebesio, TD; Yang, FC; Yang, Y; Yuan, J | 1 |
Cohn, HI; Eckhart, AD; Pesant, S; Zhou, RH | 1 |
3 review(s) available for lysophosphatidic acid and Disease Models, Animal
Article | Year |
---|---|
The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.
Topics: Animals; Asthma; Cell Movement; Dendritic Cells; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Gene Knock-In Techniques; Humans; Lung; Lymph Nodes; Lysophospholipids; Macrophages, Alveolar; Mice; Mice, Knockout; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction; Th2 Cells | 2020 |
Polyunsaturated lysophosphatidic acid as a potential asthma biomarker.
Topics: Adult; Airway Remodeling; Allergens; Animals; Asthma; Biomarkers; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Inflammation; Lung; Lysophosphatidylcholines; Lysophospholipids; Mice; Phospholipases A1; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid | 2016 |
Mediators of pruritus during cholestasis.
Topics: Animals; Bile Acids and Salts; Cholestasis; Disease Models, Animal; Humans; Lysophospholipids; Mice; Multienzyme Complexes; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pruritus; Pyrophosphatases; Signal Transduction | 2011 |
85 other study(ies) available for lysophosphatidic acid and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites.
Topics: Animals; Anti-Bacterial Agents; Azoxymethane; Bacteria; Bacterial Translocation; Cell Proliferation; Cell Transformation, Neoplastic; Colon; Colorectal Neoplasms; Diet, High-Fat; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Genes, APC; Germ-Free Life; Humans; Lysophospholipids; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Permeability; Tumor Cells, Cultured | 2022 |
Intentional endometrial injury enhances angiogenesis through increased production and activation of MMP-9 by TNF-α and MMP-3 in a mouse model.
Topics: Adult; Animals; Cells, Cultured; Disease Models, Animal; Endometrium; Endothelial Cells; Enzyme Activation; Epithelial Cells; Female; Humans; Lysophospholipids; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Neovascularization, Physiologic; Signal Transduction; Tumor Necrosis Factor-alpha; Wounds and Injuries | 2021 |
Asthmatic allergen inhalation sensitises carotid bodies to lysophosphatidic acid.
Topics: Allergens; Animals; Asthma; Carotid Body; Disease Models, Animal; Lysophospholipids; Male; Rats; Rats, Inbred BN; Rats, Sprague-Dawley | 2021 |
Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Disease Models, Animal; Fatty Acids, Unsaturated; Hippocampus; Humans; Lipids; Lysophospholipids; Male; Mice, Transgenic; Phospholipids; Presenilin-1; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sphingosine; tau Proteins | 2021 |
Joint Damage and Neuropathic Pain in Rats Treated With Lysophosphatidic Acid.
Topics: Animals; Arthralgia; Arthritis, Experimental; Disease Models, Animal; Female; Hyperalgesia; Injections, Intra-Articular; Knee Joint; Lysophospholipids; Male; Neuralgia; Pain Threshold; Rats; Rats, Wistar | 2022 |
The ATX-LPA Axis Regulates Vascular Permeability during Cerebral Ischemic-Reperfusion.
Topics: Animals; Capillary Permeability; Disease Models, Animal; Endothelial Cells; Ischemic Stroke; Lysophospholipids; Mice; Phosphoric Diester Hydrolases; Reperfusion | 2022 |
Efficacy Comparison of LPA
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Lung; Lysophospholipids; Mice; Mice, Inbred BALB C; Mucins; Ovalbumin | 2022 |
Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
Topics: Animals; Depression; Disease Models, Animal; Fluorescein; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Mice; Mice, Inbred MRL lpr; Microglia | 2023 |
The Autotaxin-LPA Axis Emerges as a Novel Regulator of Smooth Muscle Cell Phenotypic Modulation during Intimal Hyperplasia.
Topics: Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Hyperplasia; Mice; Myocytes, Smooth Muscle; Neointima; Phenotype | 2023 |
Protective Effect of Phosphatidylserine Blockade in Hemorrhagic Shock.
Topics: Animals; Annexin A5; Disease Models, Animal; Female; Humans; Infusions, Intravenous; Intestinal Mucosa; Kidney; Lung; Lysophospholipids; Organ Dysfunction Scores; Phosphatidylserines; Rats; Resuscitation; Shock, Hemorrhagic; Treatment Outcome | 2020 |
Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1α.
Topics: Animals; Atherosclerosis; Cell Movement; Disease Models, Animal; Down-Regulation; Foam Cells; Fucosyltransferases; HEK293 Cells; Hepatocyte Nuclear Factor 1-alpha; Humans; Lysophospholipids; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Protein Processing, Post-Translational; RAW 264.7 Cells; Receptors, Lysophosphatidic Acid; Signal Transduction | 2019 |
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors.
Topics: Animals; Antipruritics; Behavior, Animal; Capsaicin; Cheek; Disease Models, Animal; Injections; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Pain; Pruritus | 2019 |
LPA
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Calcium-Binding Proteins; Disease Models, Animal; Ependyma; Ependymoglial Cells; Infant, Premature, Diseases; Isoxazoles; Lysophospholipids; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microfilament Proteins; Phagocytosis; Propionates; Receptors, Lysophosphatidic Acid | 2019 |
Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.
Topics: Animals; Cauda Equina; Constriction, Pathologic; Disease Models, Animal; Female; Gene Expression Regulation; Lysophosphatidylcholines; Lysophospholipids; Neuralgia; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; RNA, Messenger; Spinal Cord | 2019 |
Protective effect of Ganoderma atrum polysaccharides in acute lung injury rats and its metabolomics.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Biomarkers; Chromatography, High Pressure Liquid; Cytokines; Disease Models, Animal; Fatty Acids, Volatile; Ganoderma; Histidine; Lysophosphatidylcholines; Lysophospholipids; Male; Metabolomics; Polysaccharides; Rats; Rats, Sprague-Dawley; Signal Transduction; Tandem Mass Spectrometry; Taurocholic Acid; Tryptophan | 2020 |
Lysophosphatidic Acid Reduces Microregional Oxygen Supply/Consumption Balance after Cerebral Ischemia-Reperfusion.
Topics: Animals; Cell Death; Cerebral Cortex; Cerebral Veins; Cerebrovascular Circulation; Disease Models, Animal; Infarction, Middle Cerebral Artery; Lysophospholipids; Male; Microcirculation; Oxygen; Oxygen Consumption; Rats, Inbred F344; Reperfusion Injury | 2020 |
Lysophosphatidic Acid Increases Maturation of Brush Borders and SGLT1 Activity in MYO5B-deficient Mice, a Model of Microvillus Inclusion Disease.
Topics: Animals; Disease Models, Animal; Enterocytes; Lysophospholipids; Malabsorption Syndromes; Mice; Mice, Knockout; Microvilli; Mucolipidoses; Myosin Type V; Sodium-Glucose Transporter 1 | 2020 |
Lysophosphatidic Acid Regulates the Differentiation of Th2 Cells and Its Antagonist Suppresses Allergic Airway Inflammation.
Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Cell Differentiation; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Lysophospholipids; Macrophages; Mice; Plethysmography; Pyroglyphidae; Receptors, Lysophosphatidic Acid; Th2 Cells | 2021 |
Lysophosphatidic acid increased infarct size in the early stage of cerebral ischemia-reperfusion with increased BBB permeability.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Cerebral Cortex; Disease Models, Animal; Infarction, Middle Cerebral Artery; Lysophospholipids; Male; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Inbred F344; Reperfusion; Reperfusion Injury; Ribosomal Protein S6 Kinases | 2020 |
Lysophosphatidic acid receptors 2 and 3 regulate erythropoiesis at different hematopoietic stages.
Topics: Anemia, Hemolytic; Animals; Cell Differentiation; Cell Lineage; Disease Models, Animal; Erythroid Cells; Erythropoiesis; Gene Expression Regulation; Humans; Isoquinolines; K562 Cells; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Myeloid Cells; Organothiophosphates; Phenylhydrazines; Phosphatidic Acids; Receptors, Lysophosphatidic Acid; Stem Cells | 2021 |
Automated detection of mouse scratching behaviour using convolutional recurrent neural network.
Topics: Animals; Behavior, Animal; Dermatitis, Atopic; Disease Models, Animal; Female; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Neural Networks, Computer; Pruritus | 2021 |
Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis.
Topics: Animals; Behavior, Animal; Carbolines; Cerebrospinal Fluid; Disease Models, Animal; Female; Ganglia, Spinal; Humans; Lysophosphatidylcholines; Lysophospholipids; Mice; Neuralgia; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats, Sprague-Dawley; Spinal Canal; Spinal Stenosis | 2021 |
Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5.
Topics: Animals; Caco-2 Cells; Cell Line; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Intestinal Mucosa; Lysophospholipids; Male; Mice; Permeability; Receptors, Lysophosphatidic Acid | 2021 |
Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance.
Topics: Animals; Cell Differentiation; Cells, Cultured; Dibenzazepines; Disease Models, Animal; Enterocytes; Humans; Intestinal Mucosa; Jejunum; Lysophospholipids; Malabsorption Syndromes; Mice; Mice, Knockout; Microvilli; Mucolipidoses; Myosin Type V; Organoids; Primary Cell Culture; Receptors, Notch; Stem Cells; Wnt Signaling Pathway | 2021 |
Primed to die: an investigation of the genetic mechanisms underlying noise-induced hearing loss and cochlear damage in homozygous Foxo3-knockout mice.
Topics: Animals; Cell Death; Disease Models, Animal; Female; Forkhead Box Protein O3; Gene Expression Regulation; Hair Cells, Auditory, Outer; Hearing; Hearing Loss, Noise-Induced; Homozygote; Lysophospholipids; Male; Mice, Knockout; Noise; Phosphoric Diester Hydrolases; Time Factors | 2021 |
Nervous system delivery of antilysophosphatidic acid antibody by nasal application attenuates mechanical allodynia after traumatic brain injury in rats.
Topics: Administration, Intranasal; Animals; Antibodies; Brain; Brain Injuries, Traumatic; Disease Models, Animal; Hyperalgesia; Lysophospholipids; Male; Pain Measurement; Rats; Rats, Sprague-Dawley | 2017 |
Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis.
Topics: Animals; Cell Differentiation; Cell Line; Connective Tissue Growth Factor; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibrosis; Focal Adhesion Kinase 1; Integrin alphaV; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myoblasts; Phosphorylation; Signal Transduction | 2018 |
LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model.
Topics: Animals; Corpus Callosum; Cuprizone; Disease Models, Animal; Female; Gene Expression; Lysophospholipids; Male; Mice, Inbred Strains; Multiple Sclerosis; Neuralgia; Receptors, Lysophosphatidic Acid; Signal Transduction | 2018 |
Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders.
Topics: Animals; Astrocytes; Cells, Cultured; Central Nervous System Agents; Cerebral Cortex; Disease Models, Animal; Glutamic Acid; Humans; Ketamine; Lysophospholipids; Mental Disorders; Mice, Inbred C57BL; Mice, Transgenic; Neural Inhibition; Phosphoric Diester Hydrolases; Proteoglycans; Psychotropic Drugs; Synapses; Tissue Culture Techniques; Vesicular Transport Proteins | 2018 |
Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain.
Topics: 2-Aminoadipic Acid; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Chemokine CXCL1; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Neuralgia; Pain Measurement; Pain Threshold; Pyridines; RNA, Messenger; Sciatic Neuropathy; Spinal Cord; Up-Regulation | 2018 |
Targeting the Nav1.8 ion channel engenders sex-specific responses in lysophosphatidic acid-induced joint neuropathy.
Topics: Activating Transcription Factor 3; Aniline Compounds; Animals; Arthralgia; Disease Models, Animal; Exploratory Behavior; Female; Furans; Hyperalgesia; Knee Joint; Lysophospholipids; Male; NAV1.8 Voltage-Gated Sodium Channel; Pain Measurement; Rats; Rats, Wistar; Sex Characteristics; Stilbamidines | 2019 |
Molecular mechanism of lysophosphatidic acid-induced hypertensive response.
Topics: Animals; Biomarkers; Disease Models, Animal; Disease Susceptibility; Fluorescent Antibody Technique; GTP-Binding Protein alpha Subunits, G12-G13; Hypertension; Lysophospholipids; Mice; rho-Associated Kinases; Signal Transduction | 2019 |
Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.
Topics: Animals; Cell Differentiation; Chronic Disease; Colitis; Dextran Sulfate; Disease Models, Animal; Enzyme Inhibitors; Inflammation; Lysophospholipids; Mice; Phosphoric Diester Hydrolases; Th17 Cells | 2019 |
Fear extinction and acute stress reactivity reveal a role of LPA(1) receptor in regulating emotional-like behaviors.
Topics: Amygdala; Animals; Conditioning, Classical; Corticosterone; Cues; Disease Models, Animal; Emotions; Extinction, Psychological; Fear; Gene Expression Regulation; Isoxazoles; Lysophospholipids; Male; Mice; Mice, Knockout; Neurons; Phosphopyruvate Hydratase; Propionates; Receptors, Lysophosphatidic Acid; Stress, Psychological; Time Factors | 2014 |
Interleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model.
Topics: Animals; Antibodies, Neutralizing; Disease Models, Animal; Gene Expression Regulation; Group IV Phospholipases A2; Interleukin-1beta; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Neuralgia; Phospholipases A2, Calcium-Independent; Posterior Horn Cells; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.
Topics: Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Inflammation; Lysophospholipids; Male; Mice; Mice, Transgenic; Phosphoric Diester Hydrolases; Signal Transduction | 2013 |
Group VIA phospholipase A2 mediates enhanced macrophage migration in diabetes mellitus by increasing expression of nicotinamide adenine dinucleotide phosphate oxidase 4.
Topics: Animals; Atherosclerosis; Cell Movement; Cells, Cultured; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Group VI Phospholipases A2; Hydrogen Peroxide; Lysophospholipids; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; Oligonucleotides, Antisense; Receptors, LDL; Signal Transduction; Stress, Physiological; Time Factors; Transfection; Up-Regulation | 2014 |
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.
Topics: Adult; Aged, 80 and over; Animals; Brain Injuries; Cytokines; Disease Models, Animal; Female; Glasgow Coma Scale; Humans; Immunoglobulin G; Immunologic Factors; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Middle Aged; Single-Blind Method; Young Adult | 2014 |
Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.
Topics: Animals; Cell Culture Techniques; Cell Proliferation; Collagen Type I; Connective Tissue Growth Factor; Disease Models, Animal; DNA-Binding Proteins; Female; Humans; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Middle Aged; Myofibroblasts; NIH 3T3 Cells; Nipecotic Acids; Oncogene Proteins, Fusion; Scleroderma, Systemic; Serum Response Factor; Trans-Activators; Transcription, Genetic; Transforming Growth Factor beta | 2014 |
Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice.
Topics: Animals; Bone and Bones; Bone Remodeling; Bone Resorption; Calcification, Physiologic; Cell Differentiation; Disease Models, Animal; Female; Femur; Humans; Immunoenzyme Techniques; Isoxazoles; Lysophospholipids; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Propionates; Receptors, Lysophosphatidic Acid; Signal Transduction; X-Ray Microtomography | 2015 |
Lysophosphatidic acid induces anxiety-like behavior via its receptors in mice.
Topics: Analysis of Variance; Animals; Anxiety; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Lysophospholipids; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Reaction Time; Receptors, Lysophosphatidic Acid; Time Factors | 2015 |
Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Dizocilpine Maleate; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuralgia; Paclitaxel; Pain Measurement; Phospholipases A2; Piperidines; Receptors, Lysophosphatidic Acid; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spinal Cord Dorsal Horn; Time Factors | 2014 |
LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage.
Topics: Animals; Behavior, Animal; Brain; Disease Models, Animal; Female; Intracranial Hemorrhages; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors; Schizophrenia; Signal Transduction | 2015 |
A transgenic mouse model for the in vivo bioluminescence imaging of the expression of the lysophosphatidic acid receptor 3: relevance for inflammation and uterine physiology research.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Female; Fluorescent Antibody Technique, Indirect; Humans; Image Processing, Computer-Assisted; Inflammation; Luciferases; Luminescent Measurements; Lysophospholipids; Male; Mice; Mice, Transgenic; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Uterus | 2015 |
Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
Topics: Animals; Animals, Newborn; Cell Death; Cells, Cultured; Cerebral Cortex; Demyelinating Diseases; Disease Models, Animal; Evoked Potentials, Motor; Female; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Motor Activity; Oligodendroglia; Receptors, Lysophosphatidic Acid; Spinal Cord; Spinal Cord Injuries; Time Factors | 2015 |
Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.
Topics: Alcohol Oxidoreductases; Animals; Brain; Cerebellum; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; DNA-Binding Proteins; Gene Knock-In Techniques; Glycerophospholipids; Huntingtin Protein; Huntington Disease; Lysophospholipids; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Phosphatidic Acids; Synaptic Vesicles; Synaptosomes | 2015 |
Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions.
Topics: Animals; Antigens, CD34; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cell Differentiation; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Cord Blood Stem Cell Transplantation; Cytokines; Disease Models, Animal; Fetal Blood; Hematopoietic Stem Cells; Humans; Ischemia; Lysophospholipids; Male; Myocardial Infarction; PPAR gamma; Rats; Signal Transduction; Treatment Outcome | 2015 |
Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Extracellular Matrix; Heterografts; Humans; Lysophospholipids; Male; Neoplasm Invasiveness; NF-kappa B; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; rhoA GTP-Binding Protein; Signal Transduction | 2016 |
An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
Topics: Animals; Benzoates; Bleomycin; Case-Control Studies; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Fibrosis; Humans; Immunohistochemistry; Interleukin-6; Lysophospholipids; Mice; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Scleroderma, Systemic; Skin | 2016 |
Lysophosphatidic acid-induced RhoA signaling and prolonged macrophage infiltration worsens fibrosis and fatty infiltration following rotator cuff tears.
Topics: Animals; Disease Models, Animal; Female; Fibrosis; Lysophospholipids; Macrophages; Muscular Atrophy; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; Rotator Cuff; Rotator Cuff Injuries | 2017 |
Autotaxin-Lysophosphatidic Acid Axis Acts Downstream of Apoprotein B Lipoproteins in Endothelial Cells.
Topics: Animals; Animals, Genetically Modified; Apolipoproteins B; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Gene Expression Profiling; Genotype; Green Fluorescent Proteins; Human Umbilical Vein Endothelial Cells; Humans; Hyperlipidemias; Lysophospholipids; Mutation; Neovascularization, Physiologic; Oligonucleotide Array Sequence Analysis; Phenotype; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction; Transcription Factors; Zebrafish; Zebrafish Proteins | 2016 |
Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain.
Topics: Animals; Biophysics; Bone Neoplasms; Cancer Pain; Carcinoma; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Female; Ganglia, Spinal; Gene Expression Regulation, Neoplastic; Hyperalgesia; Isoxazoles; Lysophospholipids; Membrane Potentials; NAV1.8 Voltage-Gated Sodium Channel; Neurons; Pain Measurement; Patch-Clamp Techniques; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid | 2016 |
Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease.
Topics: Albuminuria; Animals; Disease Models, Animal; Down-Regulation; Female; Fibrosis; Gene Expression; Kidney; Lysophospholipids; Mice; Nephrectomy; Nephritis, Interstitial; Nerve Tissue Proteins; Phosphatidate Phosphatase; Phosphorylation; Renal Insufficiency, Chronic | 2016 |
Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Heterografts; Humans; Lysophospholipids; Mice; Models, Biological; Ovarian Neoplasms; Protein Binding; Proto-Oncogene Proteins c-jun; Tumor Burden | 2016 |
Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice.
Topics: Animals; Atherosclerosis; Cholesterol, LDL; Disease Models, Animal; Endocytosis; Humans; Isoxazoles; Lysophospholipids; Mice; Propionates; Receptors, LDL; Receptors, Lysophosphatidic Acid; Signal Transduction | 2016 |
Daily Intake of High-Fat Diet with Lysophosphatidic Acid-Rich Soybean Phospholipids Augments Colon Tumorigenesis in Kyoto Apc Delta Rats.
Topics: Animals; Azoxymethane; Carcinogenesis; Carcinogens; Cell Transformation, Neoplastic; Colon; Colonic Neoplasms; Complex Mixtures; Dextran Sulfate; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Food-Drug Interactions; Glycine max; Intestinal Mucosa; Lysophospholipids; Rats; Statistics as Topic | 2017 |
Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Topics: Animals; Cell Line; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3 beta; Isoxazoles; Kidney Cortex; Lysophospholipids; Male; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Phosphorylation; Propionates; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction; Smad2 Protein; Smad3 Protein; Sterol Regulatory Element Binding Protein 1; Time Factors; Transfection; Transforming Growth Factor beta | 2017 |
Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cytokines; Disease Models, Animal; Doxycycline; Female; Humans; Inflammation; Inflammation Mediators; Lysophospholipids; Macrophages; Mice; Neovascularization, Pathologic; NF-kappa B; Phosphorylation; Protein Transport; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling.
Topics: Animals; Breast Neoplasms; Carcinogenesis; CD36 Antigens; Cell Proliferation; Cells, Cultured; Diet; Disease Models, Animal; Endothelium, Vascular; Female; Humans; Lysophospholipids; Mice; Mice, Inbred C57BL; Obesity; Protein Kinase C; Receptors, Estrogen; Risk; Signal Transduction; Vascular Remodeling | 2017 |
Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2.
Topics: Animals; Colon; Diarrhea; Disease Models, Animal; Intestinal Absorption; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Microvilli; Phosphoproteins; Receptors, Lysophosphatidic Acid; Signal Transduction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Water | 2010 |
Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.
Topics: Animals; Antigens, Protozoan; Asthma; Bronchoalveolar Lavage Fluid; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Egg Proteins; Goblet Cells; Inflammation Mediators; Lung; Lysophospholipids; Mice; Mice, Knockout; Receptors, Lysophosphatidic Acid; Schistosoma mansoni; Signal Transduction; Th2 Cells; Time Factors | 2009 |
Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain.
Topics: Animals; Calpain; Cysteine Proteinase Inhibitors; Demyelinating Diseases; Disease Models, Animal; Enzyme Activation; Leucine; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Associated Glycoprotein; Neurotoxins; Peripheral Nervous System Diseases; Receptors, Lysophosphatidic Acid; Sciatic Neuropathy; Sensory Receptor Cells; Spinal Nerve Roots | 2010 |
Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Topics: Adult; Aged; Animals; Calcium; Cell Line, Tumor; Cholestasis, Intrahepatic; Chromatography, High Pressure Liquid; Disease Models, Animal; Drainage; Female; Fluorometry; Humans; Injections, Intradermal; Liver Cirrhosis, Biliary; Lysophospholipids; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Middle Aged; Multienzyme Complexes; Neurons; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pregnancy; Pregnancy Complications; Pruritus; Pyrophosphatases; Severity of Illness Index; Time Factors; Up-Regulation | 2010 |
The sensitization of peripheral C-fibers to lysophosphatidic acid in bone cancer pain.
Topics: Animals; Blotting, Western; Bone Neoplasms; Disease Models, Animal; Female; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Lysophospholipids; Neoplasm Transplantation; Nerve Fibers, Unmyelinated; Neurons; Pain; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Signal Transduction; Sural Nerve | 2010 |
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.
Topics: Animals; Apolipoprotein A-I; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drinking Behavior; Female; Humans; Injections; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Ovarian Neoplasms; Peptides; Precancerous Conditions; Survival Analysis; Tumor Burden; Water | 2010 |
MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
Topics: Adenocarcinoma; Adenomatous Polyposis Coli; Animals; Cell Movement; Colonic Neoplasms; Disease Models, Animal; Genes, APC; GTP-Binding Protein alpha Subunits, G12-G13; GTP-Binding Protein alpha Subunits, Gq-G11; HCT116 Cells; Humans; Inositol Phosphates; JNK Mitogen-Activated Protein Kinases; Lysophospholipids; Membrane Proteins; Mice; Neoplasm Invasiveness; NF-kappa B; Phospholipase C beta; Phosphoproteins; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction; Sodium-Hydrogen Exchangers; Time Factors; Tissue Array Analysis; Transfection | 2011 |
Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.
Topics: Adipocytes; Adipose Tissue, Brown; Adipose Tissue, White; Adiposity; Animals; Blood Glucose; Cell Size; Dietary Fats; Disease Models, Animal; Female; Founder Effect; Gene Deletion; Glucose Tolerance Test; Insulin; Lysophospholipids; Male; Mice; Mice, Knockout; Multienzyme Complexes; Obesity; Phosphodiesterase I; Phosphoric Diester Hydrolases; PPAR gamma; Pyrophosphatases | 2011 |
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.
Topics: Administration, Cutaneous; Administration, Oral; Amino Acid Sequence; Animals; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Feces; Female; Gene Deletion; Inflammation; Intestinal Mucosa; Lipoproteins, HDL; Liver; Lysophospholipids; Mice; Mice, Knockout; Molecular Mimicry; Molecular Sequence Data; Peptides; Serum Amyloid A Protein | 2011 |
The molecular mechanism of cholestatic pruritus.
Topics: Animals; Calcium Signaling; Case-Control Studies; Cell Line, Tumor; Cholestasis; Cholestasis, Intrahepatic; Disease Models, Animal; Female; Humans; Lysophospholipids; Mice; Multienzyme Complexes; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pregnancy; Pregnancy Complications; Pruritus; Pyrophosphatases | 2011 |
Lysophosphatidic acid signaling may initiate fetal hydrocephalus.
Topics: Animals; Brain; Cerebral Hemorrhage; Cerebrospinal Fluid; Disease Models, Animal; Female; Fetal Diseases; Fetus; Humans; Hydrocephalus; Infant, Newborn; Lysophospholipids; Mice; Neural Stem Cells; Plasma; Pregnancy; rac GTP-Binding Proteins; Receptors, Lysophosphatidic Acid; rho GTP-Binding Proteins; Serum; Signal Transduction | 2011 |
The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.
Topics: Animals; Anoikis; Apoptosis; Bleomycin; Caspase 3; Cell Adhesion; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Fibroblasts; Humans; Lung; Lung Injury; Lysophospholipids; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Fibrosis; Rats; Receptors, Lysophosphatidic Acid; Signal Transduction; Time Factors | 2012 |
The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation.
Topics: Angioplasty; Animals; Apolipoproteins E; Blood Vessel Prosthesis Implantation; Carotid Arteries; Cell Movement; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Humans; Lysophospholipids; Macrophages; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Neointima; Postoperative Complications; Proteins; Receptors, CXCR4; Sirolimus | 2012 |
Pharmacological characterization of lysophosphatidic acid-induced pain with clinically relevant neuropathic pain drugs.
Topics: Amines; Analgesics; Animals; Calcium Channels; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Ganglia, Spinal; Hyperalgesia; Indomethacin; Lysophospholipids; Male; Mice; Morphine; Motor Activity; Neuralgia; Neurons; Pregabalin; Spinal Cord | 2012 |
Lpa2 is a negative regulator of both dendritic cell activation and murine models of allergic lung inflammation.
Topics: Administration, Inhalation; Adoptive Transfer; Allergens; Animals; Asthma; Dendritic Cells; Disease Models, Animal; Female; Gene Deletion; HEK293 Cells; Humans; Inflammation; Lung; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Receptors, Lysophosphatidic Acid; Signal Transduction; Transcription, Genetic | 2012 |
PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12.
Topics: Amino Acid Motifs; Animals; Apoptosis Regulatory Proteins; Bleomycin; Cell Movement; Disease Models, Animal; Enzyme Activation; Enzyme Stability; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; GTP-Binding Protein alpha Subunits, G12-G13; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Lung; Lysophospholipids; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiprotein Complexes; Phosphorylation; Protein Kinase C-delta; Protein Stability; Proteins; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; RNA Interference; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Trans-Activators; Transfection; Ubiquitin-Protein Ligases; Ubiquitination | 2012 |
Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Cell Death; Cell Proliferation; Cell Survival; CHO Cells; Cricetinae; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Lysophospholipids; Mice; Microglia; Motor Activity; Neurites; Neuroprotective Agents; Receptors, Lysophosphatidic Acid; Recovery of Function; Signal Transduction; Spinal Cord Injuries; Zebrafish | 2012 |
Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Female; Humans; Lysophospholipids; Male; Middle Aged; Phosphoric Diester Hydrolases; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vitreous Body; Young Adult | 2013 |
Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain.
Topics: Adenosine Triphosphate; Amino Acid Chloromethyl Ketones; Analysis of Variance; Animals; Calcium-Binding Proteins; Carrier Proteins; Cathepsin B; CD11b Antigen; CD4 Antigens; Cells, Cultured; Chromogranin A; Chronic Pain; Cyclooxygenase 2; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Freund's Adjuvant; Functional Laterality; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Inflammation; Interleukin-18; Interleukin-1beta; Lysophospholipids; Lysosomes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microfilament Proteins; Microglia; Motor Activity; Nerve Tissue Proteins; NLR Family, Pyrin Domain-Containing 3 Protein; Pain Threshold; RNA, Small Interfering; Spinal Cord; Transfection | 2012 |
Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia.
Topics: Animals; Carotid Artery Injuries; Carotid Artery, Common; Cell Movement; Cell Proliferation; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Genotype; HEK293 Cells; Humans; Hydrolysis; Hyperplasia; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Phenotype; Phosphatidate Phosphatase; rho-Associated Kinases; Signal Transduction; Time Factors; Transfection | 2013 |
LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.
Topics: Anilides; Animals; Benzamides; Biphenyl Compounds; Cell Proliferation; Chlorhexidine; Connective Tissue Growth Factor; Cytoskeleton; Disease Models, Animal; Epithelial Cells; Epithelium; Isoxazoles; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Myofibroblasts; Peritoneal Fibrosis; Receptors, Lysophosphatidic Acid; Trans-Activators; Transcription Factors | 2013 |
Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.
Topics: Animals; Ascites; Cell Line, Tumor; Culture Media, Conditioned; Disease Models, Animal; Epithelial Cells; Epithelium; Female; Humans; Isoxazoles; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Pertussis Toxin; Propionates; Receptors, Lysophosphatidic Acid; RNA, Messenger; Stomach Neoplasms; Vascular Endothelial Growth Factor A | 2006 |
EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Intraocular Pressure; Lysophospholipids; Male; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; Reperfusion Injury; Retinal Diseases; Signal Transduction; Treatment Outcome | 2006 |
Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Topics: Actins; Analysis of Variance; Animals; Apoptosis; Cell Movement; Cell Survival; Cells, Cultured; Disease Models, Animal; Female; Ganglia, Spinal; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurofibroma; Neurofibromatosis 1; Neurofibromin 1; Phosphatidylinositol 3-Kinases; Pregnancy; Pregnancy Complications; Proto-Oncogene Proteins c-akt; ras GTPase-Activating Proteins; Schwann Cells; Signal Transduction; Statistics, Nonparametric | 2007 |
Enhanced sterol response element-binding protein in postintervention restenotic blood vessels plays an important role in vascular smooth muscle proliferation.
Topics: Animals; Aorta, Abdominal; Biomarkers; Blood Vessels; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Disease Models, Animal; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenylephrine; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; RNA, Small Interfering; Stents; Sterol Regulatory Element Binding Protein 1 | 2008 |